PhD / MD / MBBS / BDS
Singaporean/ Permanent Resident / Foreigner
Antimicrobial resistance (AMR) is a pressing threat to health. As microbes become increasingly resistant to antimicrobial agents, our ability to treat infections becomes compromised, and this erodes the health benefits achieved as a result of progressive advances in medicine and public health
The Collaborative Solutions Targeting Antimicrobial Resistance Threats in Health System (CoSTAR-HS) programme aims to build capacity, infrastructure and networking opportunities for antimicrobial resistance (AMR) research in Singapore. It is a partnership involving researchers and clinicians from the National University Health System (NUHS), Singapore General Hospital (SGH), and the Communicable Diseases Centre (CDC), funded through a Centre Grant awarded by National Medical Research Council (NMRC).
The focus of the CoSTAR-HS Antimicrobial Resistance Research Grant (CoSTAR-HS ARG) is to encourage exploratory and developmental research projects by providing support for the early and conceptual stage research. It is intended for innovative research projects that
Develop and strengthen inter-institutional research collaboration or networks in Singapore
Need to utilize the facility cores developed under CoSTAR-HS
Details on facility cores can be found
here (internet accessible link).
Details on research themes can be found here (internet accessible link).
Funding DetailsFunding support of up to S$50,000 per project spanning no more than 12 months.
SingHealth PIs are to please refer to your respective Institutional Research Administrators for guidance on internal deadlines and submission procedures set by your institutions.
NUS Contact Person:Ms Zunairah Binti Lukman Email: firstname.lastname@example.org
Ms Quake Ai LiEmail: email@example.com
Additional InformationCoSTAR-HS ARG Application Form.doc